. . . . . . . "[However, telaprevir demonstrated lower potency than boceprevir against HCV G3a enzyme (Ki=75 nM vs. 17 nM), in the G3a replicon assay (EC??=953 nM vs. 159 nM), and against HCV G3a NS3 isolates (IC??=3312 nM vs. 803 nM) in the cell-based assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:18:41+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .